169 related articles for article (PubMed ID: 37831636)
1. KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1.
Xiao B; Xiang Q; Deng Z; Chen D; Wu S; Zhang Y; Liang Y; Wei S; Luo G; Li L
Carcinogenesis; 2023 Dec; 44(12):809-823. PubMed ID: 37831636
[TBL] [Abstract][Full Text] [Related]
2. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
3. A novel ER-microtubule-binding protein, ERLIN2, stabilizes Cyclin B1 and regulates cell cycle progression.
Zhang X; Cai J; Zheng Z; Polin L; Lin Z; Dandekar A; Li L; Sun F; Finley RL; Fang D; Yang ZQ; Zhang K
Cell Discov; 2015; 1():15024. PubMed ID: 27462423
[TBL] [Abstract][Full Text] [Related]
4. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
5. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
6. ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways.
Wang G; Liu G; Wang X; Sethi S; Ali-Fehmi R; Abrams J; Zheng Z; Zhang K; Ethier S; Yang ZQ
BMC Cancer; 2012 Jun; 12():225. PubMed ID: 22681620
[TBL] [Abstract][Full Text] [Related]
7. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
8. Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells.
Wang G; Zhang X; Lee JS; Wang X; Yang ZQ; Zhang K
Biochem J; 2012 Sep; 446(3):415-25. PubMed ID: 22690709
[TBL] [Abstract][Full Text] [Related]
9. Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications.
Chae SW; Sohn JH; Kim DH; Choi YJ; Park YL; Kim K; Cho YH; Pyo JS; Kim JH
Yonsei Med J; 2011 May; 52(3):445-53. PubMed ID: 21488187
[TBL] [Abstract][Full Text] [Related]
10. CCDC106 promotes non-small cell lung cancer cell proliferation.
Zhang X; Zheng Q; Wang C; Zhou H; Jiang G; Miao Y; Zhang Y; Liu Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(16):26662-26670. PubMed ID: 28460455
[TBL] [Abstract][Full Text] [Related]
11. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
[TBL] [Abstract][Full Text] [Related]
12. Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol.
Androic I; Krämer A; Yan R; Rödel F; Gätje R; Kaufmann M; Strebhardt K; Yuan J
BMC Cancer; 2008 Dec; 8():391. PubMed ID: 19113992
[TBL] [Abstract][Full Text] [Related]
13. The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance.
Fei F; Qu J; Liu K; Li C; Wang X; Li Y; Zhang S
Lab Invest; 2019 Apr; 99(4):483-498. PubMed ID: 30487595
[TBL] [Abstract][Full Text] [Related]
14. Cyclin b1 suppresses colorectal cancer invasion and metastasis by regulating e-cadherin.
Fang Y; Liang X; Jiang W; Li J; Xu J; Cai X
PLoS One; 2015; 10(5):e0126875. PubMed ID: 25962181
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis.
Song Y; Zhao C; Dong L; Fu M; Xue L; Huang Z; Tong T; Zhou Z; Chen A; Yang Z; Lu N; Zhan Q
Carcinogenesis; 2008 Feb; 29(2):307-15. PubMed ID: 18048386
[TBL] [Abstract][Full Text] [Related]
16. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
17. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
[TBL] [Abstract][Full Text] [Related]
18. MCTS1 promotes laryngeal squamous cell carcinoma cell growth via enhancing LARP7 stability.
Yang M; Ma B; Liu X
Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):652-660. PubMed ID: 35274760
[TBL] [Abstract][Full Text] [Related]
19. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.
Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y
Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963
[TBL] [Abstract][Full Text] [Related]
20. CyclinB1 deubiquitination by USP14 regulates cell cycle progression in breast cancer.
Liu B; Liu Y; Wang Y; Xie C; Gan M; Han T; Cao J; Wang J
Pathol Res Pract; 2019 Oct; 215(10):152592. PubMed ID: 31474315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
